- Home
- CARM vs GIFT Comparison
CARM vs GIFT Comparison
Compare CARM & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- GIFT
- Stock Information
- Founded
- CARM 2016
- GIFT 1999
- Country
- CARM United States
- GIFT United States
- Employees
- CARM N/A
- GIFT N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- GIFT Catalog/Specialty Distribution
- Sector
- CARM Health Care
- GIFT Consumer Discretionary
- Exchange
- CARM Nasdaq
- GIFT Nasdaq
- Market Cap
- CARM 41.5M
- GIFT 37.1M
- IPO Year
- CARM N/A
- GIFT N/A
- Fundamental
- Price
- CARM $0.94
- GIFT $1.62
- Analyst Decision
- CARM Strong Buy
- GIFT
- Analyst Count
- CARM 3
- GIFT 0
- Target Price
- CARM $12.67
- GIFT N/A
- AVG Volume (30 Days)
- CARM 183.3K
- GIFT 40.7K
- Earning Date
- CARM 11-07-2024
- GIFT 11-13-2024
- Dividend Yield
- CARM N/A
- GIFT N/A
- EPS Growth
- CARM N/A
- GIFT N/A
- EPS
- CARM N/A
- GIFT N/A
- Revenue
- CARM $20,268,000.00
- GIFT $106,073,749.00
- Revenue This Year
- CARM $50.40
- GIFT N/A
- Revenue Next Year
- CARM N/A
- GIFT N/A
- P/E Ratio
- CARM N/A
- GIFT N/A
- Revenue Growth
- CARM 41.13
- GIFT N/A
- 52 Week Low
- CARM $0.80
- GIFT $0.50
- 52 Week High
- CARM $3.16
- GIFT $4.65
- Technical
- Relative Strength Index (RSI)
- CARM 40.39
- GIFT N/A
- Support Level
- CARM $0.96
- GIFT N/A
- Resistance Level
- CARM $1.01
- GIFT N/A
- Average True Range (ATR)
- CARM 0.06
- GIFT 0.00
- MACD
- CARM -0.01
- GIFT 0.00
- Stochastic Oscillator
- CARM 4.74
- GIFT 0.00
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.